Clinical trialPhase 2Unknown
Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis
Effectiveness and Safety Evaluation of Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis: A Prospective, Single-center, Single-arm, Phase II Clinical Study
- Outcome
- Outcome unknown
- Phase
- Phase 2
- Status
- Unknown
- Study type
- Interventional
- Start
- January 2021
- Expected end
- December 2022
- Enrollment
- 50 participants
- Sites
- 1
- Primary outcomes
- OS
- Sponsor
- Other
- Results posted
- No
- Last update
- 21 December 2020
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 9
- BackgroundPercutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenoca… DOI 10.3348/kjr.2019.0647↗
- BackgroundGemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer. DOI 10.1007/s00280-018-3611-y↗
- BackgroundDose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review a… DOI 10.1016/j.ijsu.2017.10.066↗
- BackgroundDownstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? DOI 10.1245/s10434-017-5885-4↗
- BackgroundRadical surgery of oligometastatic pancreatic cancer. DOI 10.1016/j.ejso.2016.10.023↗
- BackgroundPancreatic cancer. DOI 10.1016/s0140-6736(16)00141-0↗
- BackgroundEfficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes… DOI 10.1200/jco.2014.55.1481↗
- BackgroundIncreased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. DOI 10.1056/nejmoa1304369↗
- BackgroundRadiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma. DOI 10.1016/j.jvir.2012.01.080↗